The top 10 best-selling diabetes drugs of 2013 June 17, 2014 | By Eric Palmer Everybody knows that diabetes is an epidemic in this country that is costing lives and money. New stats from the U.S. Centers for Disease Control and Prevention (CDC) peg at 29.1 million the number of people in the U.S. who […]
NCPA Supports H.R. 4577 to Benefit Seniors; Rejects Misleading PBM Attacks by NCPA | Jul 22, 2014 Alexandria, Va. July 22, 2014 – National Community Pharmacists Association (NCPA) CEO B. Douglas Hoey, RPh, MBA issued the following statement disputing a cost estimate released today by representatives of the pharmacy benefit manager (PBM) industry regarding H.R. […]
EMRs and ePrescribing: More Than “Ready” for Pharma Feature Articles by Mark Heinold on June 16th, 2014 Few facets of medicine and healthcare have experienced the rapid growth witnessed in Electronic Medical/Health Records (EMRs/EHRs) and ePrescribing over the past five years. Yet we regularly hear pundits speaking about whether EMRs are “ready” for pharma, and […]
Big Pharma’s Favorite Prescription: Higher Prices By Robert Langreth May 08, 2014 Earl Harford, a retired professor who lives in Tucson, recently bought a month’s worth of the pills he needs to keep his leukemia at bay. The cost: $7,676, three times more than when he began taking the pills in 2001. Over the years […]
Trxade Health, Inc. (NASDAQ: MEDS)